APA

Kelley-Hedgepeth A., Peter I., Kip K., Montefusco M., Kogan S., Cox D., Ordovas J., Levy D., Reis S., Mendelsohn M., Housman D. & Huggins G. (20081028). The protective effect of KCNMB1 E65K against hypertension is restricted to blood pressure treatment with beta-blockade. : Journal of human hypertension.

Chicago

Kelley-Hedgepeth A, Peter I, Kip Ke, Montefusco Mc, Kogan S, Cox D, Ordovas Jm, Levy D, Reis Se, Mendelsohn Me, Housman D and Huggins Gs. 20081028. The protective effect of KCNMB1 E65K against hypertension is restricted to blood pressure treatment with beta-blockade. : Journal of human hypertension.

Harvard

Kelley-Hedgepeth A., Peter I., Kip K., Montefusco M., Kogan S., Cox D., Ordovas J., Levy D., Reis S., Mendelsohn M., Housman D. and Huggins G. (20081028). The protective effect of KCNMB1 E65K against hypertension is restricted to blood pressure treatment with beta-blockade. : Journal of human hypertension.

MLA

Kelley-Hedgepeth A, Peter I, Kip Ke, Montefusco Mc, Kogan S, Cox D, Ordovas Jm, Levy D, Reis Se, Mendelsohn Me, Housman D and Huggins Gs. The protective effect of KCNMB1 E65K against hypertension is restricted to blood pressure treatment with beta-blockade. : Journal of human hypertension. 20081028.